Overview / Abstract: |
Target Audience This activity is intended for community-based and academic/specialist hematologists, medical oncologists, hematologic oncologists, pathologists, radiologic oncologists, surgical oncologists, primary care providers, oncology nurses and nurse navigators, nurse practitioners, physician assistants, and pharmacists. Learning Objectives At the conclusion of this activity, participants will be able to: Discuss coordination of care and clinical strategies to decrease the time to diagnosis for patients with rare cancers and blood disorders |
Expiration |
Nov 12, 2021 |
Discipline(s) |
Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME |
Format |
Online |
Credits / Hours |
1.0 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty Catherine M. Broome, MD Steven Horwitz, MD Ayalew Tefferi, MD Robert J. Kreitman, MD Jonathan C. Trent, MD, PhD Lori J. Wirth, MD Jonathan Strosberg, MD Michael C. Heinrich, MD, FACP Ghassan Abou-Alfa, MD, MBA |
Sponsors / Supporters / Grant Providers |
Daiichi Sankyo, Inc.; Deciphera Pharmaceuticals, LLC.; Eisai Inc.; Epizyme Inc.; Innate Pharma, Inc.; Ipsen Biopharmaceuticals, Inc.; Karyopharm Therapeutics; Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc.; Sanofi Genzyme; and Seattle Genetics, Inc. |
Keywords / Search Terms |
Relias LLC FREE CME., Relias LLC., GIST Free CE CME |